Blocking of stromal cell-derived factor-1 reduces neoangiogenesis in human endometriosis lesions in a mouse model.
about
Endometriosis: where are we and where are we going?Pathophysiology and Immune Dysfunction in EndometriosisA peptide inhibitor of synuclein-γ reduces neovascularization of human endometriotic lesions.IL-17A Contributes to the Pathogenesis of Endometriosis by Triggering Proinflammatory Cytokines and Angiogenic Growth FactorsImmune-inflammation gene signatures in endometriosis patients.
P2860
Blocking of stromal cell-derived factor-1 reduces neoangiogenesis in human endometriosis lesions in a mouse model.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Blocking of stromal cell-deriv ...... osis lesions in a mouse model.
@en
Blocking of stromal cell-deriv ...... osis lesions in a mouse model.
@nl
type
label
Blocking of stromal cell-deriv ...... osis lesions in a mouse model.
@en
Blocking of stromal cell-deriv ...... osis lesions in a mouse model.
@nl
prefLabel
Blocking of stromal cell-deriv ...... osis lesions in a mouse model.
@en
Blocking of stromal cell-deriv ...... osis lesions in a mouse model.
@nl
P2093
P2860
P356
P1476
Blocking of stromal cell-deriv ...... osis lesions in a mouse model.
@en
P2093
Andrew K Edwards
Chandrakant Tayade
Richard Thomas
Sophia Virani
Timothy Childs
P2860
P304
P356
10.1111/AJI.12134
P577
2013-05-07T00:00:00Z